Patrick Veit-Haibach
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiother Oncol 2020; 150:62-69.
Jun 12, 2020Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Jun 12, 2020Radiother Oncol 2020; 150:62-69
Riesterer Oliver, Pruschy Martin, Bender Sabine, Sharma Ashish, Bogowicz Marta, Tanadini-Lang Stephanie, Stieb Sonja, Bertogg Kaja, Weber Sandra, Ikenberg Kristian, Huber Gerhard, Schmid Stephan, Bredell Marius, Veit-Haibach Patrick, Rordorf Tamara, Held Ulrike, Glanzmann Christoph, Studer Gabriela
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
de Galiza Barbosa F, Stolzmann P, Huellner M, Huber G, Pruschy M, Studer G, Stieb S, Tanadini-Lang S, Riesterer O, Veit-Haibach P. Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma. Head & neck 2019; 42:163-170.
Nov 9, 2019Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
Nov 9, 2019Head & neck 2019; 42:163-170
de Galiza Barbosa Felipe, Stolzmann Paul, Huellner Martin W, Huber Gerhard, Pruschy Martin, Studer Gabriela, Stieb Sonja, Tanadini-Lang Stephanie, Riesterer Oliver, Veit-Haibach Patrick
FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.
Schneider P, Eshmuminov D, Rordorf T, Vetter D, Veit-Haibach P, Weber A, Bauerfeind P, Samaras P, Lehmann K. FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study. BMC cancer 2018; 18:548.
May 9, 2018FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.
May 9, 2018BMC cancer 2018; 18:548
Schneider Paul M, Eshmuminov Dilmurodjon, Rordorf Tamara, Vetter Diana, Veit-Haibach Patrick, Weber Achim, Bauerfeind Peter, Samaras Panagiotis, Lehmann Kuno
Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT
Sekine T, Veit-Haibach P, von Schulthess G, Kollias S, Huber G, Ter Voert E, Stolzmann P, Burger I, Delso G, Barbosa F, Huellner M. Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT. Head & neck 2017; 39:1550-1558.
May 13, 2017Local resectability assessment of head and neck cancer: Positron emission tomography/MRI versus positron emission tomography/CT
May 13, 2017Head & neck 2017; 39:1550-1558
Sekine Tetsuro, Veit-Haibach Patrick, von Schulthess Gustav K, Kollias Spyros S, Huber Gerhard, Ter Voert Edwin E, Stolzmann Paul, Burger Irene A, Delso Gaspar, Barbosa Felipe de Galiza, Huellner Martin W
PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system
Sekine T, Veit-Haibach P, von Schulthess G, Kollias S, Huber G, Stolzmann P, Burger I, Kuhn F, de Galiza Barbosa F, Huellner M. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system. Clin Imaging 2017; 42:232-239.
Jan 17, 2017PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system
Jan 17, 2017Clin Imaging 2017; 42:232-239
Sekine Tetsuro, Veit-Haibach Patrick, von Schulthess Gustav K, Kollias Spyros S, Huber Gerhard, Stolzmann Paul, Burger Irene A, Kuhn Felix P, de Galiza Barbosa Felipe, Huellner Martin W
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study
Pietsch C, de Galiza Barbosa F, Hüllner M, Schmid D, Haerle S, Huber G, Studer G, Hany T, Veit-Haibach P. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study. BMC Med Imaging 2015; 15:60.
Dec 29, 2015Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study
Dec 29, 2015BMC Med Imaging 2015; 15:60
Pietsch Carsten, de Galiza Barbosa Felipe, Hüllner Martin W, Schmid Daniel T, Haerle Stephan K, Huber Gerhard, Studer Gabriela, Hany Thomas F, Veit-Haibach Patrick
Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI
Meerwein C, Queiroz M, Kollias S, Hüllner M, Veit-Haibach P, Huber G. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI. Swiss Med Wkly 2015; 145:w14116.
Feb 21, 2015Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI
Feb 21, 2015Swiss Med Wkly 2015; 145:w14116
Meerwein Christian Martin, Queiroz Marcelo A, Kollias Spyros, Hüllner Martin, Veit-Haibach Patrick, Huber Gerhard
Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn F, Hüllner M, Mader C, Kastrinidis N, Huber G, von Schulthess G, Kollias S, Veit-Haibach P. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?. J Nucl Med 2014; 55:551-8.
Feb 3, 2014Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Feb 3, 2014J Nucl Med 2014; 55:551-8
Kuhn Felix P, Hüllner Martin, Mader Caecilia E, Kastrinidis Nikos, Huber Gerhard, von Schulthess Gustav K, Kollias Spyros, Veit-Haibach Patrick
Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT
Strobel K, Haerle S, Stöckli S, Schrank M, Soyka J, Veit-Haibach P, Hany T. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT. European journal of nuclear medicine and molecular imaging 2009; 36:919-27.
Jun 1, 2009Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT
Jun 1, 2009European journal of nuclear medicine and molecular imaging 2009; 36:919-27
Strobel Klaus, Haerle Stephan K, Stöckli Sandro, Schrank Madeleine, Soyka Jan D, Veit-Haibach Patrick, Hany Thomas F